Texas is suing 23andMe to prevent the genetic testing firm from selling personal data of state residents as the company's ...

The possible sale of 23andMe’s genetic data could set a precedent for future cases where companies look to offload ...

Regeneron signed a deal with China-based Hansoh Pharma for HS-20094, an investigational, late-stage anti-obesity asset. Per ...

Health secretary Robert F. Kennedy Jr. yesterday appointed a new, smaller vaccine advisory committee at the CDC — just two ...

A company like 23andMe can answer a lot of questions for an adoptee. But those answers come with a high cost to privacy.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the 13 Biotech Stocks with Huge Upside Potential. JPMorgan has ...

Multiple states and the District Columbia are pushing back on bankrupt 23andMe’s plans to sell customer genetic information ...

A talk with study author on a new combination of acimtamig and an allogeneic natural killer cell product that shows safety ...

The DNA of 15 million people was sold after 23andMe filed for bankruptcy and was acquired by pharmaceutical giant Regeneron.

Lawmakers raised questions and concerns about the sale of genetic-testing company 23andMe during a hearing on Tuesday.